690 — Uni-Bio Science Balance Sheet
0.000.00%
- HK$597.12m
- HK$526.06m
- HK$586.21m
Annual balance sheet for Uni-Bio Science, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 83.6 | 98.2 | 129 | 170 | 169 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 71.6 | 57.9 | 59.5 | 101 | 117 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 202 | 200 | 238 | 319 | 334 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 57.8 | 67.6 | 120 | 148 | 184 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 268 | 292 | 410 | 518 | 580 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 92.3 | 90.3 | 115 | 123 | 104 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 93.3 | 97.7 | 153 | 192 | 167 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 174 | 195 | 257 | 326 | 413 |
| Total Liabilities & Shareholders' Equity | 268 | 292 | 410 | 518 | 580 |
| Total Common Shares Outstanding |